Patents by Inventor John Finberg

John Finberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
    Publication number: 20070100001
    Abstract: The subject invention provides methods of treating a subject afflicted with Parkinson's disease, memory disorder, depression, hyperactive syndrome, Attention Deficit Disorder, dementia, brain ischemia, stroke, head trauma injury, spinal trauma injury, neurotrauma, neurodegenerative disease, neurotoxic injury, multiple sclerosis, nerve damage, affective illness, schizophrenia or symptoms of withdrawal from an addictive substance, using the mesylate salt of R(+)-N-propargyl-1-aminoindan.
    Type: Application
    Filed: November 10, 2006
    Publication date: May 3, 2007
    Inventors: Moussa Youdim, John Finberg, Ruth Levy, Jeffrey Sterling, David Lerner, Tirtsah Berger-Paskin, Haim Yellin, Izila Yeilin, Alexander Veinberg
  • Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
    Publication number: 20060094783
    Abstract: The subject invention provides methods of treating a subject afflicted with Parkinson's disease, memory disorder, depression, hyperactive syndrome, Attention Deficit Disorder, dementia, brain ischemia, stroke, head trauma injury, spinal trauma injury, neurotrauma, neurodegenerative disease, neurotoxic injury, multiple sclerosis, nerve damage, affective illness, schizophrenia or symptoms of withdrawal from an addictive substance, using the mesylate salt of R(+)-N-propargyl-1-aminoindan.
    Type: Application
    Filed: June 17, 2005
    Publication date: May 4, 2006
    Inventors: Moussa Youdim, John Finberg, Ruth Levy, Jeffrey Sterling, David Lerner, Tirtsah Berger-Paskin, Haim Yellin, Tzila Yellin, Alex Veinberg, Veinberg Alexander
  • Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase
    Patent number: 5486541
    Abstract: N-propargyl-1-amonoindan monofluorinated in the phenyl ring and their use as selective inhibitors of monoamine oxidase (MAO).There are provided several processes for the preparation of these novel compounds. There are also provided as novel compounds 1-aminoindans monofluorinated in the phenyl ring, which serve as intermediates in the preparation of the corresponding novel N-propargyl derivatives.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: January 23, 1996
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Jeff Sterling, Ruth Levy, Alex Veinberg, Willy Goldenberg, John Finberg, Musa Youdim, Arieh Gutman